As of 2026-04-16, the Fair Value of ImmuPharma PLC (IMM.L) is -9.59 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.86 GBP, the upside of ImmuPharma PLC is -297.48%.
With the market price of 4.86 GBP and our fair value calculation, ImmuPharma PLC (IMM.L) is not a good investment. Investing in IMM.L stocks now will result in a potential loss of 297.48%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -6.86 | -8.17 | -3.81 | -2.92 | -2.48 | -4.85 |
| YoY growth | -12.02% | -19.15% | 53.42% | 23.26% | 15.00% | 12.10% |
| Market Cap (mil) | 24.12 |
| P/E | |
| Forward P/E |
| EPS | -0.79 |
| Avg earnings growth rate | 12.10% |
| TTM earnings | -3.94 |